Back
Beam Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Sell
45
BEAM
Beam Therapeutics
Last Price:
24.83
Seasonality Move:
29.02%
Buy
64
LLY
Eli Lilly and
Last Price:
783.51
Seasonality Move:
1.62%
Sell
45
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy, Sell or Hold?
- The current Beam Therapeutics [BEAM] share price is $24.62. The Score for BEAM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- BEAM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $770.00. The Score for LLY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BEAM Stock Price Chart
What is Beam Therapeutics's stock price today?
-
The Beam Therapeutics share price today is $24.62
The current trend is relatively stagnant and BEAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $770.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing slight selling pressure.
BEAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.89 | Sell |
| Relative Strength Index (14 RSI): | 50.97 | Buy |
| Chaikin Money Flow: | 820935 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.93 - 24.45) | Buy |
| Bollinger Bands (100): | (23.39 - 34.29) | Sell |
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.96 | Buy |
| Relative Strength Index (14 RSI): | 53.03 | Buy |
| Chaikin Money Flow: | -418938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (736.7 - 773.3) | Buy |
| Bollinger Bands (100): | (659.62 - 785.64) | Buy |
BEAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.3 | Buy |
| 20-day SMA: | 22.79 | Buy |
| 50-day SMA: | 27.84 | Sell |
| 200-day SMA: | 26.69 | Sell |
| 8-day EMA: | 23.6 | Buy |
| 20-day EMA: | 23.81 | Buy |
| 50-day EMA: | 26.24 | Sell |
| 200-day EMA: | 28.87 | Sell |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 769.55 | Buy |
| 20-day SMA: | 757.72 | Buy |
| 50-day SMA: | 760.26 | Buy |
| 200-day SMA: | 646 | Buy |
| 8-day EMA: | 769 | Buy |
| 20-day EMA: | 763.13 | Buy |
| 50-day EMA: | 752.61 | Buy |
| 200-day EMA: | 651.12 | Buy |
Beam Therapeutics Earnings Growth & BEAM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.51 per share, and an increase next year of $0.00 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.91 per share, an increase next quarter of $0.07 per share, an increase this year of $7.48 per share, and an increase next year of $5.24 per share.
Beam Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eli Lilly and Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||